TREATMENT AND OUTCOME IN EARLY-ONSET BIPOLAR DISORDER

早发性双相情感障碍的治疗和结果

• 批准号: 7608233
• 负责人: VIVIAN KAFANTARIS
• 金额: $ 2.93万
• 依托单位: FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-04-01 至 2008-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7608233
• 关键词: Adolescent; Aggressive behavior; Antipsychotic Agents; Bipolar Disorder; Computer Retrieval of Information on Scientific Projects Database; Funding; Goals; Grant; Institution; Maintenance; Manic; Morbidity - disease rate; Neurocognitive; Patients; Pharmaceutical Preparations; Research; Research Personnel; Resources; Sampling; Short-Term Course; Source; Treatment outcome; United States National Institutes of Health; early onset; functional outcomes

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The long term goal of this project is to develop treatment regiments to minimize the morbidity associated with early-onset bipolar disorder. Once specific aim of the proposed study is to critically assess the efficacy of adjunctive antipsychotic medication during maintenance treatment of mania with psychotic feature or severe aggression in adolescents. The second specific aim is to describe the short-term course, neurocognitive functioning and functional outcomes of patients in our sample.

该副本是利用众多研究子项目之一 由NIH/NCRR资助的中心赠款提供的资源。子弹和 调查员（PI）可能已经从其他NIH来源获得了主要资金， 因此可以在其他清晰的条目中代表。列出的机构是 对于中心，这不一定是调查员的机构。 该项目的长期目标是开发治疗方案，以最大程度地减少与早发性躁郁症相关的发病率。 拟议的研究的具体目的是批判性地评估辅助性抗精神病药物在维持具有精神病特征或青少年侵略性严重攻击的躁狂症期间的辅助性抗精神病药物的功效。 第二个具体目的是描述样本中患者的短期病程，神经认知功能和功能结果。